Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
No Jitters*
By lowering the list price of our innovative medicines, were removing cost barriers and helping millions of people living with obesity and diabetes access these important medicines, specifically those whose outofpocket costs are tied to list price, including people with high-deductible health plans or co-insurance Learn more in our press release here: #PRESS Novo Nordisk faces a recalibration: rating cuts and lower forecasts after mixed latestage data sharpen competitive dynamics in obesity therapeutics
Warnings: Allergic Reactions: Do not use in patients with known vitamin B12 hypersensitivity
The clinic emphasizes that their medications come from third-party tested pharmacies, which is an important quality assurance detail
As a result, Novo Nordisk has lowered the price of GLP-1 drugs
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
US$ 28.52
US$ 23.38
US$ 24.17
US$ 24.54
